Krystal Biotech Inc

NASDAQ:KRYS  
48.82
+2.56 (+5.53%)
Other Pre-Announcement

Krystal Biotech Reports Q3 Loss Per Share $0.49

Published: 11/09/2020 13:31 GMT
Krystal Biotech Inc (KRYS) - Krystal Biotech Reports Third Quarter 2020 Financial Results and Provides Update on Operational Progress.
Q3 Loss per Share $0.49.
Q3 Earnings per Share Estimate $-0.47 -- Refinitiv Ibes Data (analyst estimates).
Cash, Cash Equivalents and Short-term Investments Totaled $286.4 Million on September 30, 2020.
Pivotal Gem-3 Study of B-vec in Deb Expected to Complete Enrollment in Early 2021.
Announced Additional in Vivo Preclinical Data Supporting Development of Kb407 in Cystic Fibrosis.